NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

ATLANTA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:

Roper Technologies, Inc. (ROP) Q4 2025 Earnings Call Transcript

Northrop Grumman Corporation (NOC) Q4 2025 Earnings Call Transcript

Northeast Bank (NBN) Q2 2026 Earnings Call Transcript

Late January brought snow, ice, and single-digit to sub-zero temperatures throughout much of the United States. In advance of that, several energy stocks rallied hard, particularly those tied to natural gas.

President Donald Trump threatened to hike tariffs on goods imported from South Korea to 25%, citing the failure of the country's legislature to codify the trade deal. The new rate would apply to autos, lumber, pharmaceutical products and "all other Reciprocal TARIFFS", under which the president set a 15% levy on South Korean exports.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Vistagen Therapeutics Class Action Lawsuit?

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Bath & Body Works Shareholders Between June 4, 2024 and November 19, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit

RLI Corp. delivered an outstanding FY2025, with a combined ratio of 83.6% and $403 million in net income, confirming its best-in-class underwriting model. Underwriting discipline remains the core of the thesis, with RLI prioritizing margin over growth across niche property and surety lines. Dividend growth remains well supported with a 10% increase in 2025, a $2 special dividend, and a payout ratio below 20%.

MMSI's WRAPSODY reimbursement tailwinds, expanding high-margin portfolio and strong cash flow set up growth into 2026 despite macro and forex headwinds.

MKS (MKSI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Simmons First National (SFNC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Integra Resources Corp. (ITRG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

UnitedHealth experienced a 20% single-day drop, but I view this as a major overreaction given its strong fundamentals. UNH's 2026 guidance signals a shift from growth to margin recovery, with adjusted EPS targeted at $17.75+ and operating margin at 5.5%. Management is exiting unprofitable Medicaid states and focusing on higher-margin business, accepting a 2% revenue decline for improved profitability.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Redwire was part of a $151 billion defense contract award to support President Donald Trump's 'Golden Dome' project. Trump announced the $175 billion missile defense system in May as part of a push to revamp and modernize the U.S. military.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Klarna Group Shareholders Who Purchased Pursuant to the September 2025 IPO - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit